INFLIXIMAB CLEARANCE PRE-THERAPY AND DURING INDUCTION PREDICTS LONG TERM DISEASE CONTROL IN INFLAMMATORY BOWEL DISEASE

被引：0
|
作者：
Vermeire, Severine
D'Haens, Geert
Laharie, David
Dreesen, Erwin
Rabizadeh, Shervin
Jain, Anjali
Spencer, Elizabeth A.
Panetta, John C.
Dubinsky, Marla
Dervieux, Thierry
机构：
来源：
GASTROENTEROLOGY | 2022年 / 162卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
234
引用
收藏
页码：S45 / S46
页数：2
相关论文
共 50 条
  • [41] Infliximab clearance decreases in the second and third trimesters of pregnancy in inflammatory bowel disease
    Grisic, Ana-Marija
    Dorn-Rasmussen, Maria
    Ungar, Bella
    Brynskov, Jorn
    Ilvemark, Johan F. K. F.
    Bolstad, Nils
    Warren, David J.
    Ainsworth, Mark A.
    Huisinga, Wilhelm
    Ben-Horin, Shomron
    Kloft, Charlotte
    Steenholdt, Casper
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2021, 9 (01) : 91 - 101
  • [42] Post induction infliximab trough levels predict long-term endoscopic remission in paediatric patients with inflammatory bowel disease
    van Hoeve, K.
    Dreesen, E.
    Hoffman, I.
    Ferrante, M.
    Vermeire, S.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S362 - S363
  • [43] Antiphospholipid antibody induction after infliximab treatment for inflammatory bowel disease
    Wheeler, Jason
    VASCULAR MEDICINE, 2021, 26 (05) : NP32 - NP33
  • [44] Usefulness of therapeutic drug monitoring of infliximab during the induction period in patients with inflammatory bowel disease
    Gil Candel, Mayte
    Gascon Canovas, Juan Jose
    Urbieta Sanz, Elena
    Gomez Espin, Rosa
    Nicolas de Prado, Isabel
    Iniesta Navalon, Carles
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2020, 112 (05) : 360 - 366
  • [45] A role for therapeutic drug-monitoring during infliximab induction treatment in inflammatory bowel disease?
    Rasmussen, M.
    Brynskov, J.
    Ainsworth, M. A.
    Buhl, S.
    Bendtzen, K.
    Steenholdt, C.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S378 - S378
  • [46] Long-Term Safety and Efficacy of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease
    Mock, Joseph D.
    Tuskey, Anne G.
    Rubin, Amy
    Behm, Brian W.
    GASTROENTEROLOGY, 2015, 148 (04) : S257 - S257
  • [47] Long Term Prognosis After Discontinuation of Infliximab in Patients With Inflammatory Bowel Disease in Clinical Remission
    Steenholdt, Casper
    Molazahi, Akbar
    Ainsworth, Mark A.
    Brynskov, Jorn
    Thomsen, Ole
    Seidelin, Jakob B.
    GASTROENTEROLOGY, 2012, 142 (05) : S204 - S204
  • [48] Long-Term Outcome of Infliximab Optimization for Overcoming Immunogenicity in Patients with Inflammatory Bowel Disease
    Papamichael, Konstantinos
    Vajravelu, Ravy K.
    Osterman, Mark T.
    Cheifetz, Adam S.
    DIGESTIVE DISEASES AND SCIENCES, 2018, 63 (03) : 761 - 767
  • [49] Long-Term Outcome of Infliximab Optimization for Overcoming Immunogenicity in Patients with Inflammatory Bowel Disease
    Konstantinos Papamichael
    Ravy K. Vajravelu
    Mark T. Osterman
    Adam S. Cheifetz
    Digestive Diseases and Sciences, 2018, 63 : 761 - 767
  • [50] Long-term clinical outcome after infliximab discontinuation in patients with inflammatory bowel disease
    Lee, Ji Min
    Kim, Yoon Jae
    Lee, Kang-Moon
    Yoon, Hyuk
    Lee, Bo-In
    Kim, Dae Bum
    Kang, Donghoon
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2018, 53 (10-11) : 1280 - 1285
12345